Meyka Pro banner
Cerus Corporation

Cerus Corporation (CERS) Stock Overview

Explore Cerus Corporation’s financial performance, market position, analyst ratings, and future outlook.

CERSNASDAQ
HealthcareMedical - Devices
$3.15
$0.02(0.64%)
U.S. Market opens in 2h 18m

Cerus Corporation (CERS)

Meyka AI Score

Z

Key Financials

Market Cap631.2M
P/E Ratio-62.28
EPS (TTM)$-0.05
ROE-0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$2.99
3 Months$3.12
1 Year Target$3.18

CERS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cerus Corporation (CERS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.63, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.18.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -62.28 and a market capitalization of 631.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.64%
5-Day Change
2.61%
1-Month Change
21.15%
3-Month Change
53.66%
6-Month Change
27.02%
Year-to-Date (YTD) Change
52.91%
1-Year Change
128.26%
3-Year Change
12.50%
5-Year Change
-37.13%
All-Time (Max) Change
-74.02%

Contact Information

925 288 6000
1220 Concord Avenue, Concord, CA, 94520

Company Facts

2,750 Employees
IPO DateJan 31, 1997
CountryUS
Actively Trading

Frequently Asked Questions